AKT1 and colonic neoplasm: Evidence from in vitro, in vivo, and clinical studies highlights their role in suppressing various cancers, including breast, prostate, lung, gastric, and colon cancer, primarily through the regulation of signaling pathways, that is, MAPK/ERK and PI3K/AKT/mTOR.